Company Profile

Evofem Biosciences Stock Price, News & Analysis

Ticker:
EVFM
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

0.01 USD (+1.19%)

Close

Last updated: August 6, 2026

Market cap

Why the stock is moving

As of Aug 6, 2026, EVFM closed up 1.19% at $0.0085. No new same-company headline was identified in the current news window.

Company overview

Business overview

Evofem Biosciences was a women’s health biotechnology company focused on contraceptive and sexual health products before becoming a historical ticker. Its story reflected the difficulty of commercializing a focused women’s-health asset base.

Geographic Base and Sector Classification

Evofem was headquartered in the United States and listed on NASDAQ. It sat in specialty biopharma and women’s health.

Business Model Characteristics

The business depended on product adoption, commercialization execution, and financing. Investors historically watched revenue, market access, and whether the company could sustain its product franchise.

Position Within the Biotechnology Landscape

Evofem is best viewed as a historical women’s-health biotech name. Its stock was driven more by commercial and capital structure issues than by broad pipeline optionality.

Future catalysts

Evofem is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live women’s-health milestone. The market is mainly focused on what remains.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Evofem Biosciences (EVFM)?

    Evofem Biosciences (EVFM) most recently closed at 0.01 USD, a +1.19% move versus the previous session.

    What does Evofem Biosciences do?

    Evofem Biosciences was a women’s health biotechnology company focused on contraceptive and sexual health products before becoming a historical ticker. Its story reflected the difficulty of commercializing a focused women’s-health asset base.

    On which exchange is EVFM stock listed?

    Evofem Biosciences (EVFM) is associated with NASDAQ, United States, Biopharma.

    What is Evofem?

    Evofem is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live women’s-health milestone.

    Which conditions is Evofem Biosciences targeting with Evofem?

    Evofem is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live women’s-health milestone.

    How does Evofem Biosciences describe recent progress with Evofem?

    Evofem is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live women’s-health milestone.

    What is Biosciences?

    Evofem Biosciences was a women’s health biotechnology company focused on contraceptive and sexual health products before becoming a historical ticker.

    What should investors watch for with Biosciences?

    Evofem is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live women’s-health milestone. The market is mainly focused on what remains.